Fig. 4.

The effect of baricitinib on mortality. (A) and (B) Based on the forest plots for RCTs and nRCTs, respectively, baricitinib does reduce mortality significantly in COVID-19 patients without significant heterogeneity. (C) Based on the funnel plot, no publication bias was spotted in Fig. 4B (nRCTs). The authors had contacted Falcone et al. [31] on 4^th February 2022 for additional information and received the information on 7^th February 2022 from Dr. Giusy Tiseo, a co-author. Falcone et al. [31] supplied information related to mortality and BDP for Propensity score (PS)-matched analysis.